{"nct_id":"NCT06393374","title":"Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2024-06-24","start_date_type":"ACTUAL","primary_completion_date":"2030-12-16","primary_completion_date_type":"ESTIMATED","completion_date":"2037-12-14","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}